Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UVA1 versus 5-MOP UVA photochemotherapy in severe generalized atopic dermatitis
2006-006982-17Phase 4Completed
- Sponsor
- Division of Special and Environmental Dermatology
- Start
- Mar 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bergapten in atopic dermatitis (AD) (2 arms), sponsored by Division of Special and Environmental Dermatology. Primary endpoint: Duration of remission based on SCORAD. Started Mar 2007; status: completed.
02
Drugs
bergapten
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2006-006982-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006982-17.